A retrospective analysis of ezrin protein and mRNA expression in breast cancer: Ezrin expression is associated with patient survival and survival of patients with receptor‐positive disease
Abstract Introduction The cytoskeletal protein ezrin is upregulated in many cancer types and is strongly associated with poor patient outcome. While the clinical and prognostic value of ezrin has been previously evaluated in breast cancer, most studies to date have been conducted in smaller cohorts...
Main Authors: | Sarah J. Storr, Victoria Hoskin, Radhika Aiyappa‐Maudsley, Abdi Ghaffari, Sonal Varma, Andrew Green, Emad Rakha, Ian O. Ellis, Peter A. Greer, Stewart G. Martin |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-05-01
|
Series: | Cancer Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1002/cam4.5802 |
Similar Items
-
Perspectives for Targeting Ezrin in Cancer Development and Progression
by: Jean Carlos Lipreri da Silva, et al.
Published: (2023-01-01) -
Up Regulation of Ezrin and Radixin with respect to Grade of Tumors in Breast Cancer Patients
by: Hadiseh Mohammadpour, et al.
Published: (2023-10-01) -
Hypoxia and Ezrin Expression in Primary Melanoma Have High Prognostic Relevance
by: Umberto Maccio, et al.
Published: (2022-09-01) -
Pathophysiological Roles of Actin-Binding Scaffold Protein, Ezrin
by: Kotoku Kawaguchi, et al.
Published: (2022-03-01) -
Ez-Metastasizing: The Crucial Roles of Ezrin in Metastasis
by: Rand Gabriel M. Buenaventura, et al.
Published: (2023-06-01)